| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |